Are you sure you'd like to remove this alert? You will no longer receive email updates about this topic.
US animal health firm Zomedica Pharmaceuticals has achieved a number of milestones for its pet therapeutics pipeline in 2017.
Swedish firm Oasmia Pharmaceuticals is aiming to list its veterinary assets on the Nasdaq through its wholly-owned US subsidiary.
Animal health firms Vetanco and Dr Bata have joined forces in the US to open a new subsidiary.
UK aquaculture specialist Benchmark is already ahead of its predicted earnings for fiscal 2017.
Boehringer Ingelheim Vetmedica (BIVI) is pre-empting an increased demand for veterinary vaccines by spending $80 million on expanding its existing facilities in Athens, Georgia and St Joseph, Missouri.
Japanese animal nutrition specialist Feed One will invest ¥11 billion ($98 million) in constructing a new manufacturing plant in Kitakyushu by April 2020.
French feed additive company Olmix has opened its first Asian production facility in southern Vietnam.
Aratana Therapeutics is aiming to raise $35 million through a public offering of its common stock.
US feed additive firm Alltech is aiming to capitalize on recent strong growth in Cambodia by opening its first office there.
After a turbulent year in the Australian animal health sector the appointment of Dr Chris Parker as chief executive of the Australian Pesticides and Veterinary Medicines Authority (APVMA) suggests a brighter future for the industry.
Henry Schein Animal Health has further increased its domestic distribution network by investing $1.7 million in a new warehousing center in Southaven, Mississippi.
All set! This article has been sent to firstname.lastname@example.org.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
Please Note: Only individuals with an active subscription will be able to access the full article. All other readers will be directed to the abstract and would need to subscribe.